News

Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
Press release: Fisher BioServices’ CryoHub to co-locate with manufacturing centrePress release: Fisher BioServices’ CryoHub to co-locate with manufacturing centreContribute to this year's manufacturing surveyContribute to this year's manufacturing surveyRegulatory news - February 2017Regulatory news - February 2017Regulatory news - January 2017Regulatory news - January 2017Regulatory news - December 2016Regulatory news - December 2016Regulatory news - November 2016Regulatory news - November 2016Keith Thompson, CEO, speaks to Manufacturing ChemistKeith Thompson, CEO, speaks to Manufacturing ChemistPress release: Autolus to manufacture at the Cell and Gene Therapy CatapultPress release: Autolus to manufacture at the Cell and Gene Therapy CatapultRegulatory news: October 2016Regulatory news: October 2016Manufacturing centre update: Why Stevenage?Manufacturing centre update: Why Stevenage?Regulatory news: September 2016Regulatory news: September 2016Press release: Investment in the cell and gene therapy industry in the UK grows 10x since 2012 to £400m/yearPress release: Investment in the cell and gene therapy industry in the UK grows 10x since 2012 to £400m/year